In order to remain economically viable, pharmacy owners have been forced to care for their patients within the context of business concerns caused by a ‘dispensing deficit’ caused by the defunct funding and regulatory context in which pharmacy practice necessarily takes place.
The study, published in JAMA Network Open, suggests that pantoprazole prophylaxis in invasively ventilated patients offers both clinical benefits and economic value for the healthcare system.